Actinium Highlights
Actinium Highlights Results from Phase 1 Clinical Trial of Actimab-A at 58th American Society of Hematology Annual Meeting
05 déc. 2016 21h00 HE | Actinium Pharmaceuticals
Analysis of 2 Actimab-A Phase 1 clinical trials show that 42% of patients with low peripheral blast (PB) burden responded to Actimab-A while no patients with high PB burden responded to Actimab-AKey...
Actinium Further Str
Actinium Further Strengthens Clinical Development Team with Senior Hire to Support Later-Stage Clinical Trials
29 nov. 2016 07h00 HE | Actinium Pharmaceuticals
NEW YORK, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Issues Lett
Actinium Issues Letter to Shareholders Highlighting 2016 Accomplishments and Anticipated Milestones for 2017
22 nov. 2016 07h00 HE | Actinium Pharmaceuticals
NEW YORK, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for...
Actinium Announces N
Actinium Announces Notice of Allowance for U.S. Patent Related to Actimab-A
14 nov. 2016 07h00 HE | Actinium Pharmaceuticals
Allowed patent application claims method for purifying actinium-225 NEW YORK, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a...
Actinium Pharmaceuti
Actinium Pharmaceuticals Announces Key Hire in Clinical Supply Chain Organization as Company Expands To Accommodate Continued Growth
31 oct. 2016 07h00 HE | Actinium Pharmaceuticals
- Incoming Industry Veteran to Lead Clinical Supply Chain Operations and Architect the Build Out of the Anticipated Commercial Supply Chain NEW YORK, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Actinium...
Actinium Pharmaceuti
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
26 oct. 2016 07h00 HE | Actinium Pharmaceuticals
- Incoming specialists to focus on Quality Control and Quality Assurance Aspects of Supply Chain NEW YORK, Oct. 26, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM)...
Actinium Pharmaceuti
Actinium Pharmaceuticals Initiates Pursuit of Scientific Advice for Iomab-B from the European Medicines Agency
25 oct. 2016 07h00 HE | Actinium Pharmaceuticals
-  Company is seeking guidance on development plan of Iomab-B for the EU market -  Actinium’s small and medium-sized (SME) status and orphan designation results in a 100% reduction in...
Actinium Announces A
Actinium Announces Acceptance of Actimab-A Data for Poster Presentation at American Society of Hematology Annual Meeting
19 oct. 2016 07h00 HE | Actinium Pharmaceuticals
NEW YORK, Oct. 19, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...
Actinium Pharmaceuti
Actinium Pharmaceuticals Granted Orphan Designation from the European Medicines Agency for Iomab-B
18 oct. 2016 07h00 HE | Actinium Pharmaceuticals
- Orphan designation is expected to provide increased communication and guidance from regulators and 10-year market exclusivity should marketing authorization be obtained - Orphan designation...
Actinium Announces C
Actinium Announces Closing of Public Offering of Common Stock
04 oct. 2016 16h15 HE | Actinium Pharmaceuticals
NEW YORK, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload...